Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Rosuvastatin Calcium × Clear all

NCT02569645 2022-07-20

Rosuvastatin in the Treatment of Rectal Cancer

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms